Upregulation of ANP32e expression is associated with increased proliferation of several cancers including triple-negative breast cancer,1 childhood acute myeloid leukemia,2 mesothelioma,3 thyroid carcinoma,4 medulloblastoma,5 pancreatic cancer,7 and lung cancer.6 This evidence concerns the gene ANP32E and mesothelioma.